YU14595A - Postupak za dobijanje epoksida - Google Patents
Postupak za dobijanje epoksidaInfo
- Publication number
- YU14595A YU14595A YU14595A YU14595A YU14595A YU 14595 A YU14595 A YU 14595A YU 14595 A YU14595 A YU 14595A YU 14595 A YU14595 A YU 14595A YU 14595 A YU14595 A YU 14595A
- Authority
- YU
- Yugoslavia
- Prior art keywords
- procedure
- epoxide
- obtaining
- obtaining epoxide
- eppxide
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 2
- 150000002118 epoxides Chemical class 0.000 title 1
- 230000015572 biosynthetic process Effects 0.000 abstract 2
- 239000004593 Epoxy Substances 0.000 abstract 1
- 108010010369 HIV Protease Proteins 0.000 abstract 1
- 108091005804 Peptidases Proteins 0.000 abstract 1
- 102000035195 Peptidases Human genes 0.000 abstract 1
- 239000004365 Protease Substances 0.000 abstract 1
- 239000003153 chemical reaction reagent Substances 0.000 abstract 1
- 150000003944 halohydrins Chemical class 0.000 abstract 1
- 239000002461 renin inhibitor Substances 0.000 abstract 1
- 229940086526 renin-inhibitors Drugs 0.000 abstract 1
- 238000007363 ring formation reaction Methods 0.000 abstract 1
- 238000003786 synthesis reaction Methods 0.000 abstract 1
- 230000002194 synthesizing effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Virology (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Molecular Biology (AREA)
- AIDS & HIV (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epoxy Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyridine Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Abstract
Postupak za sintetizovanje epoksida formule koji se sastoji od najmanje, obrazovanja halohidrina iz alii acetonid reagensa, a zatim bazom-indukovane ciklizacije, proizvod eppksid I je korisan kao intermedijar za sintezu inhibitora renina ili HIV proteaze ili drugih proteaza.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US20607494A | 1994-03-04 | 1994-03-04 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| YU14595A true YU14595A (sh) | 1997-12-05 |
| YU49010B YU49010B (sh) | 2003-04-30 |
Family
ID=22764868
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| YU14595A YU49010B (sh) | 1994-03-04 | 1995-03-03 | Postupak za sintetizovanje epoksida |
Country Status (25)
| Country | Link |
|---|---|
| EP (1) | EP0748319B1 (sh) |
| JP (1) | JP3871705B2 (sh) |
| KR (1) | KR100387741B1 (sh) |
| CN (1) | CN1066728C (sh) |
| AT (1) | ATE210662T1 (sh) |
| AU (1) | AU690231B2 (sh) |
| BR (1) | BR9506977A (sh) |
| CA (1) | CA2183976C (sh) |
| CZ (1) | CZ291816B6 (sh) |
| DE (1) | DE69524578T2 (sh) |
| DK (1) | DK0748319T3 (sh) |
| ES (1) | ES2167419T3 (sh) |
| FI (1) | FI120259B (sh) |
| HR (1) | HRP950096B1 (sh) |
| HU (1) | HU222750B1 (sh) |
| MX (1) | MX9603871A (sh) |
| NZ (1) | NZ281866A (sh) |
| PT (1) | PT748319E (sh) |
| RO (1) | RO117696B1 (sh) |
| RU (1) | RU2137769C1 (sh) |
| SK (1) | SK283067B6 (sh) |
| TW (1) | TW380137B (sh) |
| UA (1) | UA45968C2 (sh) |
| WO (1) | WO1995023797A1 (sh) |
| YU (1) | YU49010B (sh) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5728840A (en) * | 1994-03-04 | 1998-03-17 | Merck & Co., Inc. | Process for making an epoxide |
| TW415948B (en) * | 1995-10-30 | 2000-12-21 | Merck & Co Inc | Process for synthesizing epoxide and halohydrin |
| US5981759A (en) * | 1997-06-20 | 1999-11-09 | Merck & Co., Inc. | Process for indinavir intermediate |
| KR101434522B1 (ko) | 2005-11-09 | 2014-08-26 | 오닉스 세라퓨틱스, 인크. | 효소 저해를 위한 화합물 |
| US7691852B2 (en) | 2006-06-19 | 2010-04-06 | Onyx Therapeutics, Inc. | Compounds for enzyme inhibition |
| RS54847B2 (sr) | 2007-10-04 | 2019-09-30 | Onyx Therapeutics Inc | Inhibitori kristalne peptid epoksi keton proteaze i sinteza aminokiselinskih keto-epoksida |
| JP5675629B2 (ja) | 2008-10-21 | 2015-02-25 | オニキス セラピューティクス， インク．Ｏｎｙｘ Ｔｈｅｒａｐｅｕｔｉｃｓ， Ｉｎｃ． | ペプチドエポキシケトンを用いた併用療法 |
| AR075899A1 (es) | 2009-03-20 | 2011-05-04 | Onyx Therapeutics Inc | Tripeptidos epoxicetonas cristalinos inhibidores de proteasa |
| JP5919196B2 (ja) | 2009-11-13 | 2016-05-18 | オニキス セラピューティクス， インク．Ｏｎｙｘ Ｔｈｅｒａｐｅｕｔｉｃｓ， Ｉｎｃ． | 転移抑制のためのペプチドエポキシケトンの使用 |
| MA34133B1 (fr) | 2010-03-01 | 2013-04-03 | Onyx Therapeutics Inc | Composes pour inhibiteurs de l'immunoproteasome |
| RU2012151303A (ru) | 2010-04-30 | 2014-06-10 | Индиана Юниверсити Рисерч Эдн Текнолоджи Корпорейшн | Способы получения линезолида |
| US20140105921A1 (en) | 2012-07-09 | 2014-04-17 | Onyx Therapeutics, Inc. | Prodrugs of Peptide Epoxy Ketone Protease Inhibitors |
| CN104692987B (zh) * | 2015-01-22 | 2017-05-17 | 北京大学 | 卤代醇及其衍生物的廉价高效合成方法 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2072237A1 (en) * | 1991-07-02 | 1993-01-03 | Merck & Co., Inc. | Stereoselective production of hydroxyamide compounds from chiral -amino epoxides |
| EP0541168B1 (en) * | 1991-11-08 | 1998-03-11 | Merck & Co. Inc. | HIV protease inhibitors useful for the treatment of aids |
-
1995
- 1995-02-24 TW TW084101733A patent/TW380137B/zh not_active IP Right Cessation
- 1995-02-27 NZ NZ281866A patent/NZ281866A/en not_active IP Right Cessation
- 1995-02-27 CN CN95192714A patent/CN1066728C/zh not_active Expired - Lifetime
- 1995-02-27 KR KR1019960704836A patent/KR100387741B1/ko not_active Expired - Fee Related
- 1995-02-27 DK DK95911105T patent/DK0748319T3/da active
- 1995-02-27 CA CA002183976A patent/CA2183976C/en not_active Expired - Fee Related
- 1995-02-27 UA UA96103798A patent/UA45968C2/uk unknown
- 1995-02-27 BR BR9506977A patent/BR9506977A/pt not_active IP Right Cessation
- 1995-02-27 AT AT95911105T patent/ATE210662T1/de active
- 1995-02-27 RO RO96-01750A patent/RO117696B1/ro unknown
- 1995-02-27 AU AU18828/95A patent/AU690231B2/en not_active Ceased
- 1995-02-27 EP EP95911105A patent/EP0748319B1/en not_active Expired - Lifetime
- 1995-02-27 RU RU96120179A patent/RU2137769C1/ru not_active IP Right Cessation
- 1995-02-27 PT PT95911105T patent/PT748319E/pt unknown
- 1995-02-27 MX MX9603871A patent/MX9603871A/es unknown
- 1995-02-27 JP JP52294995A patent/JP3871705B2/ja not_active Expired - Fee Related
- 1995-02-27 HU HU9602412A patent/HU222750B1/hu not_active IP Right Cessation
- 1995-02-27 CZ CZ19962543A patent/CZ291816B6/cs not_active IP Right Cessation
- 1995-02-27 DE DE69524578T patent/DE69524578T2/de not_active Expired - Lifetime
- 1995-02-27 SK SK1122-96A patent/SK283067B6/sk not_active IP Right Cessation
- 1995-02-27 ES ES95911105T patent/ES2167419T3/es not_active Expired - Lifetime
- 1995-02-27 WO PCT/US1995/002347 patent/WO1995023797A1/en not_active Ceased
- 1995-03-02 HR HR950096A patent/HRP950096B1/xx not_active IP Right Cessation
- 1995-03-03 YU YU14595A patent/YU49010B/sh unknown
-
1996
- 1996-09-03 FI FI963452A patent/FI120259B/fi not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| YU14595A (sh) | Postupak za dobijanje epoksida | |
| DK0443449T3 (da) | Fremgangsmåde til fremstilling af oxetanoner | |
| DK0582790T3 (da) | Ny fremgangsmåde til fremstilling af 7-substituerede-9-[(substitueret glycyl)-amino]-6-demethyl-6-deoxytetracycliner | |
| PT931083E (pt) | Processo para a producao de compostos de ecteinascidina | |
| BRPI0013885B8 (pt) | comprimidos aperfeiçoados | |
| ES2319396T3 (es) | Nuevos nitrilos utiles como inhibidores reversibles de cisteina-proteasas. | |
| DE60123579D1 (de) | Synthese von 3,6-dialkyl-5,6-dihydro-4-hydroxy-pyran-2-one | |
| EA200300804A1 (ru) | Усовершенствованный способ получения карбапенема | |
| ATE239716T1 (de) | Synthese von 3,6-dialkyl-5,6-dihydro-4-hydroxy-2h-pyran-2-on | |
| TR200302288T2 (tr) | Terapi için yeni bileşikler ve metotlar. | |
| YU45896A (sh) | Postupak za dobijanje epoksida | |
| EA200400806A1 (ru) | Способ получения эхинокандиновых соединений | |
| YU5896A (sh) | Primena amida fenilcikloheksilkarbonske kiseline, pojedinačni amidi fenilcikloheksilkarbonske kiseline, postupak za njihovu izradu kao i lekovi koji ih sadrže | |
| EA200100040A1 (ru) | Химический синтез морфолиновых производных | |
| LV12825B (lv) | Hiv proteāzes inhibitora iegūšana | |
| BRPI0416678A (pt) | pirazolpirimidinas | |
| DE69432176D1 (de) | Verfahren zur herstellung von hiv protease inhibitoren | |
| DK1347965T3 (da) | Hidtil ukendte desloratidinsalte, fremgangsmåde til syntese deraf samt farmaceutiske præparater deraf | |
| EA200300400A1 (ru) | 17α-ФТОРАЛКИЛСТЕРОИДЫ, СПОСОБ ИХ ПОЛУЧЕНИЯ И СОДЕРЖАЩИЕ ЭТИ СОЕДИНЕНИЯ ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ | |
| SE0001866D0 (sv) | A new process | |
| ATE336493T1 (de) | Tricyclische epoxide | |
| FR2446826A1 (fr) | Tetrahydro-1h(ou 2h)indazoles tautomeres utiles comme intermediaires de synthese |